Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cresco Labs Inc

2 'Strong Buy' Cannabis Stocks Set to Gain on Spending Bill Maneuvers

The U.S. cannabis market could be on the cusp of a critical growth catalyst, presenting ripe investment opportunities for those ready to navigate its unique risks.

Barchart

Cresco vs. Tilray: Which Cannabis Stock Is a Better Buy?

Despite lingering regulatory challenges, the cannabis market is well-positioned for a steady expansion. Penny stock Cresco's solid financials and growth potential have won over analysts, while Tilray failed to impress with last quarter’s record revenue.

Barchart

'One Of Best-In-Class' Cannabis MSOs Has 'Optionality' When States Go Recreational, Bullish Analyst Says After Results

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) reported its financial results on Wednesday for the second quarter of fiscal 2022, revealing a 4% year-ove

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Cresco Labs Q1 Revenue Grows 20%, Here Are The Details

Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) (FSE:6CQ) released its financial results for the three months ended March 31, 2022, revealing revenue of $214 million, up 20% year-over-year.

Benzinga

Cresco Labs Financial Results: Record Revenue $822M For 2021, 73% YoY Increase

Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) (FSE:6CQ) released its financial results for the three months and year ended December 31, 2021. Fiscal Year 2021 Financial Highlights

Benzinga

People

Pablo Zuanic

101 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Benzinga Cannabis Capital Conference

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.